These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23525846)

  • 1. Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice.
    Heath CH; Deep NL; Beck LN; Day KE; Sweeny L; Zinn KR; Huang CC; Rosenthal EL
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):982-90. PubMed ID: 23525846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model.
    Heath CH; Deep NL; Sweeny L; Zinn KR; Rosenthal EL
    Ann Surg Oncol; 2012 Nov; 19(12):3879-87. PubMed ID: 22669455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma.
    Day KE; Beck LN; Heath CH; Huang CC; Zinn KR; Rosenthal EL
    Cancer Biol Ther; 2013 Mar; 14(3):271-7. PubMed ID: 23298904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.
    Day KE; Sweeny L; Kulbersh B; Zinn KR; Rosenthal EL
    Mol Imaging Biol; 2013 Dec; 15(6):722-9. PubMed ID: 23715932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma.
    Day KE; Beck LN; Deep NL; Kovar J; Zinn KR; Rosenthal EL
    Laryngoscope; 2013 Nov; 123(11):2681-9. PubMed ID: 23616260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer.
    Korb ML; Hartman YE; Kovar J; Zinn KR; Bland KI; Rosenthal EL
    J Surg Res; 2014 May; 188(1):119-28. PubMed ID: 24360117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
    Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
    J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic antibody improves melanoma detection by fluorescently labeled therapeutic antibodies.
    Sweeny L; Prince A; Patel N; Moore LS; Rosenthal EL; Hughley BB; Warram JM
    Laryngoscope; 2016 Dec; 126(12):E387-E395. PubMed ID: 27576611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer.
    Nishio N; van den Berg NS; van Keulen S; Martin BA; Fakurnejad S; Zhou Q; Lu G; Chirita SU; Kaplan MJ; Divi V; Colevas AD; Rosenthal EL
    Mol Imaging Biol; 2020 Feb; 22(1):156-164. PubMed ID: 31054001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Use of Panitumumab-IRDye800CW in a Novel Murine Model for Conjunctival Squamous Cell Carcinoma.
    Youn GM; Case AG; Jarin T; Li B; Swarup A; Naranjo A; Bou-Khalil C; Yao J; Zhou Q; Hom ME; Rosenthal EL; Wu AY
    Transl Vis Sci Technol; 2022 Jul; 11(7):23. PubMed ID: 35895055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Formalin Fixation for Near-Infrared Fluorescence Imaging with an Antibody-Dye Conjugate in Head and Neck Cancer Patients.
    Kapoor S; Lu G; van den Berg NS; Krishnan G; Pei J; Zhou Q; Martin BA; Baik FM; Rosenthal EL; Nishio N
    Mol Imaging Biol; 2021 Apr; 23(2):270-276. PubMed ID: 33078373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors for Differential Outcome Across Cancers in Clinical Molecule-Targeted Fluorescence Imaging.
    Zhou Q; van den Berg NS; Kang W; Pei J; Nishio N; van Keulen S; Engelen MA; Lee YJ; Hom M; Vega Leonel JCM; Hart Z; Vogel H; Cayrol R; Martin BA; Roesner M; Shields G; Lui N; Gephart MH; Raymundo RC; Yi G; Granucci M; Grant GA; Li G; Rosenthal EL
    J Nucl Med; 2022 Nov; 63(11):1693-1700. PubMed ID: 35332092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts.
    Rosenthal EL; Kulbersh BD; King T; Chaudhuri TR; Zinn KR
    Mol Cancer Ther; 2007 Apr; 6(4):1230-8. PubMed ID: 17431103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial.
    Zhou Q; van den Berg NS; Rosenthal EL; Iv M; Zhang M; Vega Leonel JCM; Walters S; Nishio N; Granucci M; Raymundo R; Yi G; Vogel H; Cayrol R; Lee YJ; Lu G; Hom M; Kang W; Hayden Gephart M; Recht L; Nagpal S; Thomas R; Patel C; Grant GA; Li G
    Theranostics; 2021; 11(15):7130-7143. PubMed ID: 34158840
    [No Abstract]   [Full Text] [Related]  

  • 15. PET of EGFR antibody distribution in head and neck squamous cell carcinoma models.
    Niu G; Li Z; Xie J; Le QT; Chen X
    J Nucl Med; 2009 Jul; 50(7):1116-23. PubMed ID: 19525473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts.
    Kulbersh BD; Duncan RD; Magnuson JS; Skipper JB; Zinn K; Rosenthal EL
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):511-5. PubMed ID: 17520766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer.
    Marston JC; Kennedy GD; Lapi SE; Hartman YE; Richardson MT; Modi HM; Warram JM
    J Surg Res; 2019 Jul; 239():44-51. PubMed ID: 30798171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular imaging of a fluorescent antibody against epidermal growth factor receptor detects high-grade glioma.
    Zhou Q; Vega Leonel JCM; Santoso MR; Wilson C; van den Berg NS; Chan CT; Aryal M; Vogel H; Cayrol R; Mandella MJ; Schonig F; Lu G; Gambhir SS; Moseley ME; Rosenthal EL; Grant GA
    Sci Rep; 2021 Mar; 11(1):5710. PubMed ID: 33707521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescently Labeled Cetuximab-IRDye800 for Guided Surgical Excision of Ameloblastoma: A Proof of Principle Study.
    Morlandt AB; Moore LS; Johnson AO; Smith CM; Stevens TM; Warram JM; MacDougall M; Rosenthal EL; Amm HM
    J Oral Maxillofac Surg; 2020 Oct; 78(10):1736-1747. PubMed ID: 32554066
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.